Internal Server Error

ErlySign - About the company

ErlySign is a seed company based in Nagpur (India), founded in 2019 by Shubhendrasingh Jitendrasingh Thakur and Deovrat Begde. It operates as a Provider of a saliva-based, non-invasive oral cancer detection platform. ErlySign has raised $2.17M in funding from LVX and Laxmi investments FZCO, with a current valuation of $*****. The company has 1489 active competitors, including 179 funded and 174 that have exited. Its top competitors include companies like Abcam, Molbio Diagnostics and Quanterix.

Company Details

Provider of a saliva-based, non-invasive oral cancer detection platform. It develops rapid screening solutions designed to identify oral cancer at its earliest stages, enabling timely diagnosis and improved clinical outcomes. Its technology is deployed across hospitals, diagnostic laboratories, and dental clinics, helping healthcare providers expand preventive screening programs, increase early-stage detection rates, and enhance patient care.
Social
XFacebook
Email ID
*****@erlysign.com
Phone Number
+91 **********
Registered Address
Plot No. 41, H.No. 1408/A, DARSHANA SOCIETY, MOUJA GOREWADA, Nagpur, NAGPUR, Maharashtra, India, 440013
Key Metrics
Founded Year
2019
Location
Nagpur, India
Stage
Seed
Total Funding
$2.17M in 5 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 26, 2024
Investors
Ranked
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
14 as on Aug 31, 2026
Similar Companies
Sign up to download ErlySign's company profile

ErlySign's funding and investors

ErlySign has raised a total funding of $2.17M over 5 rounds. Its first funding round was on 2019. Its latest funding round was a Seed round on Dec 26, 2024 for $*****. 2 investors participated in its latest round. ErlySign has 9 institutional investors and 5 angel investors.

Here is the list of recent funding rounds of ErlySign:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Dec 26, 2024
8492632
Seed
5180243
7248872
4733506
2913396
Jun 26, 2023
5002293
Seed
2582954
8364678
2417773
8258717
2023
6230
Grant (prize money)
1828
4179
8430
lockAccess funding benchmarks and valuations. Sign up today!

ErlySign's founders and board of directors

Founder? Claim Profile
The founders of ErlySign are Shubhendrasingh Jitendrasingh Thakur and Deovrat Begde. Shubhendrasingh Jitendrasingh Thakur is the CEO of ErlySign.
Here are the details of ErlySign's key team members:

ErlySign's Board of Directors

ErlySign's board has 2 active members. Shubhendrasingh Jitendrasingh Thakur is part of team and Pradnya Anil Mahatme is independent board member.
Here is the list of ErlySign's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
7y 1m
Independent board member
-
Current
4y 5m

ErlySign's employee count trend

ErlySign has 14 employees as of Aug 26. Here is ErlySign's employee count trend over the years:
Employee count trend for ErlySign
lockUncover ErlySign's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

ErlySign's Competitors and alternates

Top competitors of ErlySign include Abcam, Molbio Diagnostics and Quanterix. Here is the list of Top 10 competitors of ErlySign, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Abcam
Abcam
1998, Cambridge (United Kingdom), Acquired
Developer of biological reagents for life science research
$78.8M
76/100
2nd
Logo for Molbio Diagnostics
Molbio Diagnostics
2000, Salcete (India), Public
Developer of point-of-care molecular diagnostic platform for infectious disease detection
$124M
74/100
3rd
Logo for Quanterix
Quanterix
2007, Cambridge (United States), Public
Developer of assay kits for ultra-sensitive biomarker detection
$99.5M
71/100
4th
Logo for Fulgent Genetics
Fulgent Genetics
2011, Temple City (United States), Acquired
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
$34.8M
-
71/100
5th
Logo for Invitae
Invitae
2010, San Francisco (United States), Public
Provider of home-based genetic test for individuals
$190M
68/100
6th
Logo for Geneoscopy
Geneoscopy
2015, St. Louis (United States), Series C
Developer of non-invasive biomarker tests for colorectal cancer
$219M
67/100
7th
Logo for 4baseCare
4baseCare
2018, Bengaluru (India), Series B
Provider of precision oncology solutions, including genomic testing and digital health
$25.9M
67/100
8th
Logo for Qiagen
Qiagen
1984, Venlo (Netherlands), Acquired
Provider of products and reagents for molecular diagnostic assays
-
65/100
9th
Logo for Meridian Bioscience
Meridian Bioscience
1976, Ohio (United States), Acquired
Molecular diagnostic device and kits
-
65/100
10th
Logo for LGC
LGC
1842, Teddington (United Kingdom), Acquired
Provider of analytical testing, reference materials, and diagnostic and therapeutic products
-
65/100
121st
Logo for ErlySign
ErlySign
2019, Nagpur (India), Seed
Provider of a saliva-based, non-invasive oral cancer detection platform
$2.17M
42/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on ErlySign's competitors? Click here to see the top ones

ErlySign's Latest cap tables and shareholding

Founders (largest shareholder) own 46.41%, Funds own 9.93%, Enterprises own 15.55% and Angels own 12.64%. The net worth of ErlySign's founders is INR 30.6Cr as of Dec 26, 2024.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
46.41%
30.6Cr
6689131
4113501
4154462
6783307
8709493
6939994
8019508
8329226
9508754
9237504
4799508
7676362
3517482
1762773
1051926
7178509
Fund
9.93%
6.55Cr
8666277
2988308
2213595
3688115
Enterprise
15.55%
10.3Cr
7074212
6062199
9576084
4025630
Angel
12.64%
8.34Cr
4923724
3436790
1070422
8234651
8720939
5943165
8861906
5745213
1116431
9465284
0
0
0
0
0
0
Other People
12.37%
8.17Cr
9976923
5147317
3020927
7210391
Other Investors
3.09%
2.04Cr
268
723
758
147
Total
99.99%
66Cr
6744448
8279345
8220974
3208420
lockTo unlock detailed Cap Table of ErlySign Sign up today!
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer
View more details of ErlySign's Shareholding

ErlySign's Investments and acquisitions

ErlySign has made no investments or acquisitions yet.

Reports related to ErlySign

Here is the latest report on ErlySign's sector:

News related to ErlySign

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about ErlySign

Explore our recently published companies
  • Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
  • Boooply - 2026 founded, Unfunded company
  • Uaity - 2026 founded, Unfunded company
  • WeQuick - Chennai based, 2026 founded, Unfunded company
  • ArdFior - 2026 founded, Unfunded company
  • Luthco - New York City based, 2026 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford